OrbiMed’s Sierra Oncology, Inc. Common Stock SRRA Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2022
Q3 | – | Sell |
-1,964,770
| Closed | -$108K | – | 151 |
|
|
2022
Q2 | $108K | Hold |
1,964,770
| – | – | 1.96% | 16 |
|
|
2022
Q1 | $63M | Buy |
1,964,770
+487,450
| +33% | +$15.6M | 1.02% | 34 |
|
|
2021
Q4 | $32.1M | Hold |
1,477,320
| – | – | 0.41% | 65 |
|
|
2021
Q3 | $32.4M | Hold |
1,477,320
| – | – | 0.36% | 73 |
|
|
2021
Q2 | $28.8M | Hold |
1,477,320
| – | – | 0.29% | 80 |
|
|
2021
Q1 | $25.5M | Hold |
1,477,320
| – | – | 0.24% | 87 |
|
|
2020
Q4 | $23.7M | Hold |
1,477,320
| – | – | 0.21% | 93 |
|
|
2020
Q3 | $15.8M | Hold |
1,477,320
| – | – | 0.2% | 96 |
|
|
2020
Q2 | $17.9M | Hold |
1,477,320
| – | – | 0.25% | 81 |
|
|
2020
Q1 | $14.5M | Buy |
+1,477,320
| New | +$14.5M | 0.24% | 76 |
|
|
2019
Q2 | – | Sell |
-7,928
| Closed | -$542K | – | 136 |
|
|
2019
Q1 | $542K | Sell |
7,928
-2,500
| -24% | -$171K | 0.01% | 114 |
|
|
2018
Q4 | $551K | Sell |
10,428
-8,750
| -46% | -$462K | 0.01% | 120 |
|
|
2018
Q3 | $1.3M | Sell |
19,178
-12,500
| -39% | -$850K | 0.02% | 140 |
|
|
2018
Q2 | $3.75M | Sell |
31,678
-23,415
| -43% | -$2.77M | 0.04% | 128 |
|
|
2018
Q1 | $4.56M | Sell |
55,093
-25,000
| -31% | -$2.07M | 0.06% | 116 |
|
|
2017
Q4 | $12M | Sell |
80,093
-12,500
| -13% | -$1.87M | 0.15% | 99 |
|
|
2017
Q3 | $5.74M | Hold |
92,593
| – | – | 0.05% | 116 |
|
|
2017
Q2 | $4.33M | Hold |
92,593
| – | – | 0.05% | 115 |
|
|
2017
Q1 | $5.67M | Buy |
+92,593
| New | +$5.67M | 0.06% | 110 |
|
|
2016
Q2 | – | Sell |
-40,579
| Closed | -$10.9M | – | 143 |
|
|
2016
Q1 | $10.9M | Sell |
40,579
-9,170
| -18% | -$2.47M | 0.12% | 90 |
|
|
2015
Q4 | $29.9M | Hold |
49,749
| – | – | 0.27% | 65 |
|
|
2015
Q3 | $40.8M | Buy |
+49,749
| New | +$40.8M | 0.41% | 49 |
|